Metraipolis › archive › dc_2300550ef74f

Cancer-Testis Antigens in Immuno Oncology Mechanisms Therapeutic Strategies and Clinical Perspectives — Europe PMC PMID:42753002

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42753002
DOI
10.1155/jimr/8131644
License (as archived)
solo-consultazione
Archived
2026-11-07T05:55:44.138Z
SHA-256 of the archived text
7462f5aeebf825a69b1415f8cfe34ee9f6092a5f3741aaab883cd881663d3ece
Stable URL of this page
https://metraipolis.com/documento/dc_2300550ef74f

How to cite

Cancer-Testis Antigens in Immuno Oncology Mechanisms Therapeutic Strategies and Clinical Perspectives — Europe PMC PMID:42753002 — Europe PMC (en), https://europepmc.org/article/MED/42753002 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2300550ef74f (Metraipolis archive dc_2300550ef74f, sha256 7462f5aeebf825a69b1415f8cfe34ee9f6092a5f3741aaab883cd881663d3ece)
BibTeX
@misc{dc2300550ef74f,
  title = {Cancer-Testis Antigens in Immuno Oncology Mechanisms Therapeutic Strategies and Clinical Perspectives — Europe PMC PMID:42753002},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42753002},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2300550ef74f; sha256 7462f5aeebf825a69b1415f8cfe34ee9f6092a5f3741aaab883cd881663d3ece},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42753002. Agents can read the archived copy with the MCP tool read_document.